Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;37(9).
doi: 10.1002/gps.5792.

The cognitive performance in the Phototest is predictor of biological markers of Alzheimer's disease

Carrera-Muñoz Ismael  1 , Barrios-López José M  1 , Muñoz-Martínez Claudia  1 , Romero-Fábrega Juan C  1 , Vilchez-Carrillo Rosa M  1 , Del Ser Quijano Teodoro  2 , Carnero-Pardo Cristoba  3
Affiliations

The cognitive performance in the Phototest is predictor of biological markers of Alzheimer's disease

Carrera-Muñoz Ismael et al. Int J Geriatr Psychiatry. 2022 Sep.

Abstract

Background: The abnormal cerebrospinal fluid levels of biomarkers, such as β-amyloid and phosphorylated tau (pTau), support the biological diagnosis of Alzheimer Disease (AD) independently of its clinical stage. However, this invasive exam cannot be extensively applied and requires previous sound clinical screen that can be based on brief, well validated cognitive tests, such as the Phototest.

Objective: To evaluate the association of partial (naming [NA], total recall [TR], free recall [FR], and verbal fluency) and total scores of the Phototest with the biological diagnosis of AD and the potential use of this test as a screening tool in the clinical work up.

Design: Retrospective study of Individuals attending a Memory Clinic who were applied the Phototest and classified, according to cerebrospinal fluid biomarkers (β-amyloid1-42 and pTau), in the biological AD continuum stage (ContAD) as "no AD" (A-), "AD changes" (A+T-) or "AD" (A+T+). Multivariate analyses were conducted with one fixed factor, ContAD, and partial and total Phototest scores. The area under the receiver operating characteristics curve (AUC) was calculated to estimate the capacity of Phototest scores to predict amyloidosis (A+) and AD.

Results: The study included 170 individuals (92 A-, 23 A+T- and 55 A+T+). FR (7.9, 0.01 [F,p]) and TR (8.1, 0.001) scores were associated with ContAD and had a moderate ability (AUC 0.71-0.74) to detect the presence of "A+" or "AD".

Conclusions: Partial memory scores of Phototest are associated with ContAD. They predict acceptably the presence of abnormal levels of β-amyloid and AD signature in CSF and can be useful to support further biological diagnostic tests.

Keywords: Alzheimer; CSF biomarkers; biological continuum; cognitive performance; diagnostic work‐up; phototest.

PubMed Disclaimer

References

REFERENCES

    1. Domingues RB, Mantese CE, Aquino EDS, Fantini F, Prado GFD, Nitrini R. Telemedicine in neurology: current evidence. Arquivos de neuro‐psiquiatria. 2020;78(12):818‐826. https://doi.org/10.1590/0004‐282x20200131
    1. Niu H, Alvarez‐Alvarez I, Guillen‐Grima F, Aguinaga‐Ontoso I. Prevalence and incidence of Alzheimer's disease in Europe: a meta‐analysis. Neurologia. 2017;32(8):523‐532. https://doi.org/10.1016/j.nrleng.2016.02.009
    1. Lloret A, Esteve D, Lloret MA, et al. When does Alzheimer's disease really start? The role of biomarkers. Int J Mol Sci. 2019;20(22):5536. https://doi.org/10.3390/ijms20225536
    1. Jack CR, Jr., Bennett DA, Blennow K, et al. NIA‐AA Research Framework: toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018;14(4):535‐562. https://doi.org/10.1016/j.jalz.2018.02.018
    1. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):263‐269. https://doi.org/10.1016/j.jalz.2011.03.005

LinkOut - more resources